Ibudilast, a phosphodiesterase inhibitor, ameliorates experimental autoimmune encephalomyelitis in Dark August rats

Journal of Neuroimmunology

Volumn 95, Issue 1-2, 1999, Pages 35-42

  Fujimoto, Tetsuo ^a   Sakoda, Saburo ^a   Fujimura, Harutoshi ^a   Yanagihara, Takehiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Experimental autoimmune encephalomyelitis; Ibudilast; Multiple sclerosis; Phosphodiesterase inhibitors; Proinflammatory cytokines

Indexed keywords

IBUDILAST; PHOSPHODIESTERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; AUTOIMMUNITY; CELL INFILTRATION; CELL PROLIFERATION; CEREBROVASCULAR DISEASE; DISEASE SEVERITY; ENZYME INHIBITION; IMMUNIZATION; IN VITRO STUDY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ADMINISTRATION, ORAL; ANIMALS; CELL DIVISION; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MULTIPLE SCLEROSIS; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PYRIDINES; RATS; RATS, INBRED STRAINS; SPINAL CORD; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033103620     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00251-3     Document Type: Article

References (41)

1. Beavo J.A., Conti M., Heaslip R.J. Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol. 46:1994;399-405.
2. Duong T.T., Louis J.S., Gilbert J.J., Finkelman F.D., Strejan G.H. Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 36:1992;105-115.
3. Endres S., Fülle H.-J., Sinha B., Stoll D., Dinarello C.A., Gerzer R., Weber P.C. Cyclic nucleotides differentially regulate the synthesis of tumor necrosis factor-α and interleukin-1β by human mononuclear cells. Immunology. 72:1991;56-60.
4. Fabian R.H., Rea H.C. Neuronal toxicity by macrophages in mixes brain cell culture is augmented by antineuronal IgG and dependent upon nitric oxide synthesis. J. Neuroimmunol. 44:1993;95-102.
5. Genain C.P., Roberts T., Davis R.L., Nguyen M.H., Uccelli A., Faulds D., Li Y., Hedgpeth J., Hauser S. Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. U.S.A. 92:1995;3601-3605.
6. Greten T.F., Eigler A., Sinha B., Moeller J., Endres S. The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediator TNF-α and nitric oxide. Int. J. Immunopharmacol. 17:1995;605-610.
7. Jung S., Zielasek J., Köllner G., Donhauser T., Toyka K., Hartung H.-P. Preventive but not therapeutic application of rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats. J. Neuroimmunol. 68:1996;1-11.
8. Kambayashi T., Jacob C.O., Zhou D., Mazurek N., Fong M., Strassman G. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages. J. Immunol. 155:1995;4909-4916.
9. Kawasaki A., Hoshino K., Osaki R., Mizushima Y., Yano S. Effect of Ibudilast: a novel anti-asthmatic agent, on airway hypersensitivity in bronchial asthma. J. Asthma. 29:1992;245-252.
10. Lugnier C., Schini V.B. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells. Biochem. Pharmacol. 39:1990;75-84.
11. MacMicking J.D., Willenborg D.O., Weidemann M.J., Rockett K.A., Cowden W.D. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176:1992;303-307.
12. Merrill J.E., Kono D.H., Clayton J., Ando D.G., Hinton D.R., Hofman F.M. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10PL mice. Proc. Natl. Acad. Sci. U.S.A. 89:1992;574-578.
13. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
14. Milo R., Panitch H. Additive effects of copolymer-1 and interferon β-1b on the immune response to myelin basic protein. J. Neuroimmunol. 61:1995;185-193.
15. Munoz E., Zubiaga A.M., Merrow M., Sauter N.P., Huber B.T. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: Role of cAMP in T cell proliferation. J. Exp. Med. 172:1990;95-103.
16. Nataf S., Louboutin J.P., Chabannes D., Feve J.R., Muller J.Y. Pentoxifylline inhibits experimental allergic encephalomyelitis. Acta. Neurol. Scand. 88:1993;97-99.
17. Nicholson C.D., Shahid M. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes - their potential utility in the therapy of asthma. Pulm. Pharmacol. 7:1994;1-17.
18. Nicholson C.D., Challiss R.A.J., Shahid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol. 12:1991;19-27.
19. Ohashi M., Ohkubo H., Kito J., Nishino K. A new vasodilator 3-isobutyryl-2-isopropyl-pyrazolol[1,5-a]pyridine (KC-404) has a dual mechanism of action on platelet aggregation. Arch. Int. Pharmacodyn. Ther. 283:1986;321-334.
20. Okuda Y., Sakoda S., Fujimura H., Yanagihara T. Pentoxifylline delays the onset of experimental allergic encephalomyelitis in mice by modulating cytokine production in peripheral blood mononuclear cells. Immunopharmacology. 35:1996;141-148.
21. Okuda Y., Sakoda S., Fujimura H., Yanagihara T. Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase. J. Neuroimmunol. 81:1998;201-210.
22. Oppenheimer-Marks N., Ziff M. Migration of lymphocytes through endothelial cell monolayers: augmentation by interferon-gamma. Cell. Immunol. 114:1988;307-323.
23. Oppenheimer-Marks N., Kavanaugh A.F., Lipsky P.E. Inhibition of the transendothelial migration of human T lymphocytes by prostaglandin E2. J. Immunol. 152:1994;5703-5713.
24. Pober J.S., Slowik M.R., De Luca L.G., Ritchie A.J. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J. Immunol. 150:1993;5114-5123.
25. Raddassi K., Petit J.-F., Lemaire G. LPS-induced activation of primed murine peritoneal macrophages is modulated by prostaglandins and cyclic nucleotides. Cell. Immunol. 149:1993;50-64.
26. Renno T., Krakowski M., Piccirillo C., Lin J.-y., Owens T. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis: regulation by Th1 cytokines. J. Immunol. 154:1995;944-953.
27. Rivero V.E., Maccioni M., Bucher A.E., Roth G.A., Riera C.M. Suppression of experimental autoimmune encephalomyelitis (EAE) by intraperitoneal administration of soluble myelin antigens in Wistar rats. J. Neuroimmunol. 72:1997;3-10.
28. Rott O., Cash E., Fleischer B. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1 - but not type 2 - associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur. J. Immunol. 23:1993;1745-1751.
29. Schade F.U., Schudt C. The specific type III and IV phosphodiesterase inhibitor zardaverine suppresses formation of tumor necrosis factor by macrophages. Eur. J. Pharmacol. 230:1993;9-14.
30. Selmaj K., Papierz W., Glabinski A., Kohno T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor 1. J. Neuroimmunol. 56:1995;135-141.
31. Sinha B., Semmler J., Eisenhut T., Eigler A., Endres S. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur. J. Immunol. 25:1995;147-153.
32. Sommer N., Loschmann P.-A., Northoff G.H., Weller M., Steinbrecher A., Steinbach J.P., Lichtenfels R., Meyermann R., Riethmuller A., Fontana A., Dichgans J., Martin R. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat. Med. 1:1995;244-248.
33. Souness J.E., Diocee B.K., Martin W., Moodie S.A. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitor to evaluate their roles in regulating cyclic nucleotide levels in intact cells. Biochem. J. 266:1990;127-132.
34. Souness J.E., Scott L.C., Tomkinson A., Giembycz M.A., Raeburn D. Inhibition of cyclic nucleotide phosphodiesterase by Ibudilast: comparison with rolipram. Br. J. Pharmacol. 108:1993;71p.
35. Souness J.E., Villami M.E., Scott L.C., Tomkinson A., Giembycz M.A., Raeburn D. Possible role of cyclic AMP phosphodiesterases in the action of Ibudilast on eosinophil thromboxane generation and airways smooth muscle tone. Br. J. Pharmacol. 111:1994;1081-1088.
36. Sowa G., Przewlocki R. cAMP analogues and cholera toxin stimulate the accumulation of nitrite in rat peritoneal macrophage cultures. Eur. J. Pharmacol. 266:1994;125-129.
37. Stepaniak J.A., Gould K.E., Sun D., Swanborg R.H. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats. J. Immunol. 155:1995;2762-2769.
38. Suttorp N., Weber U., Welsch T., Schudt C. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J. Clin. Invest. 91:1993;1421-1428.
39. Tomkinson A., Sharma A., Giembycz M.A., Souness J.E., Raeburn D. Effects of Ibudilast on airways smooth muscle contraction in vitro and in vivo; Comparison with rolipram. Br. J. Pharmacol. 108:1993;73.
40. van Oosten B.W., Barkhof F., Truyen L., Boringa J.B., Bertelsmann F.W., von Blomberg B.M.E., Woody J.N., Hartung H.-P., Polman C.H. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology. 47:1996;1531-1534.
41. Zielasek J., Tausch M., Toyka K.V., Hartung H.-P. Production of nitrite by neonatal rat microglial cells/brain macrophages. Cell. Immunol. 141:1992;111-120.